Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cambridge Heart, Inc.
Cardiac device firm reports 19% revenue increase
December 7th, 2004
Cambridge Heart, Inc., (CAMH) reported revenue of $1,278,649 for the quarter ended September 30, 2004, a 9% increase over the previous quarter but a decline of 35% from revenue of $1,953,817 for the same period in 2003. The majority of the decline is due to approximately $600,000 of non-recurring revenue reported for the quarter ended September 30, 2003, from the company's sale of products to participants in the Medtronic sponsored MASTER Study and to Philips Medical Systems under the recently expired distribution agreement for our CH2000 stress test system. Net loss for the quarter was $803,420, or $0.03 per share, compared to a loss of $643,786, or...
Source: Cardiovascular Business Week (2004-12-07)
|
